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Brief CommunicationImpaired histone deacetylases 5 and 6
expression mimics the effects of obesity and
hypoxia on adipocyte functionJulien Bricambert 1,10, Dimitri Favre 2,10, Saska Brajkovic 1,2,10, Amélie Bonnefond 1, Raphael Boutry 1,
Roberto Salvi 1, Valérie Plaisance 1, Mohamed Chikri 3,4, Giulia Chinetti-Gbaguidi 5,6, Bart Staels 5,
Vittorio Giusti 7, Robert Caiazzo 8, François Pattou 8, Gérard Waeber 2, Philippe Froguel 1,9,
Amar Abderrahmani 1,9,*ABSTRACT
Objective: The goal of the study was to investigate the role of histone deacetylases (HDACs) in adipocyte function associated with obesity and
hypoxia.
Methods: Total proteins and RNA were prepared from human visceral adipose tissues (VAT) of human obese and normal weight subjects and
from white adipose tissue (WAT) of C57Bl6-Rj mice fed a normal or high fat diet (HFD) for 16 weeks. HDAC activity was measured by colorimetric
assay whereas the gene and protein expression were monitored by real-time PCR and by western blotting, respectively. RNA interference (RNAi)
was used to silence the expression of genes in 3T3-L1 adipocytes.
Results: Total HDAC activity was decreased in VAT and WAT from obese individuals and from mice fed a HFD, respectively. The HDAC activity
reduction was associated with decreased HDAC5/Hdac5 and HDAC6/Hdac6 expression in human and mice adipocyte fraction. Similarly, hypoxia
hampered total Hdac activity and reduced the expression of Hdac5 and Hdac6 in 3T3-L1 adipocytes. The decrease of both Hdac5 and Hdac6 by
hypoxia was associated with altered expression of adipokines and of the inducible cAMP early repressor (Icer), a key repressor that is defective in
human and mice obesity. Silencing of Icer in adipocytes reproduced the changes in adipokine levels under hypoxia and obesity, suggesting a
causative effect. Finally, modeling the defect of the two Hdacs in adipocytes by RNAi or selective inhibitors mimicked the effects of hypoxia on the
expression of Icer, leading to impairment of insulin-induced glucose uptake.
Conclusion: Hdac5 and Hdac6 expression are required for the adequate expression of Icer and adipocyte function. Altered adipose expression of
the two Hdacs in obesity by hypoxia may contribute to the development of metabolic abnormalities.
 2016 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords Histone deacetylases; Adipocytes; Adipokines; Obesity; Insulin resistance1. INTRODUCTION
Insulin resistance is a key feature of obesity and is involved in the
development of type 2 diabetes, fatty liver disease, cardiovascular
disease, and cancer [1e4]. Insulin resistance is associated with
altered production of several adipokines (i.e. bioactive secreted
products from adipocytes) that regulate insulin sensitivity and energy
metabolism [5e7]. These adipokines include interleukin 6 (IL6),
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(ADIPOQ), resistin (RETN), and SERPINE1 (also called plasminogen
activator inhibitor type 1) [5,6,8]. These adipokines have been shown
to induce insulin resistance in rodents [5,9,10].
In both human and mice obesity, hypoxia is thought to contribute to
impaired adipokine production [11e14]. Indeed, visceral adipose tis-
sue (VAT) from obese subjects is characterized by impaired blood ﬂow,
defective capillary density, and impaired O2 partial pressure [12,14].
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Figure 1: Measurement of Hdac/HDAC activity and expression from adipose tissues, adipocytes and svf in diet-induced obese mice, non-obese and obese individuals. A) Hdac activity in WAT of mice fed with regular or HFD. Total
proteins were prepared from WAT of mice that were fed with regular (open bars, Chow, n ¼ 10 mice) or HFD (ﬁlled bars, HFD, n ¼ 10 mice). HDACs activity was measured by direct colorimetric assay kit (Epigentek). Data are the mean  SEM
of 3 independent experiments (*p < 0.05). Quantiﬁcation of B) Class I Hdac1/2/3/8, C) Class IIa Hdac4/5/7/9 D) Class IIb Hdac6/10 IIb and IV Hdac11 mRNA levels. The mRNA of E) Hdac5, F) Hdac6, and G) Hdac9 was quantiﬁed by PCR in
adipocytes and stroma vascular fraction (SVF) that were collected from WAT from control (open bars, Chow) and obese mice (ﬁlled bars, HFD). The Hdac mRNA levels were determined by quantitative real-time PCR and were normalized against
the housekeeping acidic ribosomal phosphoprotein P0 gene (Rplp0). Similar results were obtained while normalizing against TBP. The results were expressed as the fold changes over the controls. Data are the mean of SEM of 3 independent
experiments (***P < 0.001; **P < 0.01; *P < 0.05). H) HDAC activity in VAT of non-obese and obese individuals. Total protein concentrations were prepared from VAT of non-obese (open bars, NO) or obese individuals (ﬁlled bars, Obese) and
were subjected to colorimetric assay kit (Epigentek). Data are the mean  SEM of 3 independent experiments (**P < 0.01). Quantiﬁcation of I) HDAC5, J) HDAC6, and K) HDAC9 mRNA in adipocytes and SVF from VAT of non-obese (open bars,
NO) or obese individuals (ﬁlled bars, Obese). The HDAC mRNA levels were determined by quantitative real-time PCR. The mRNA levels were normalized against the RPLP0 and were expressed as the fold changes over the controls. Data are the
mean of SEM of 3 independent experiments (**P < 0.01; *P < 0.05).
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Adipoq, Agt, Lep, Nampt, and Retn, and, in contrast, to increased
expression of Serpine1, Il6, and Lcn2 [8,11]. However, the molecular
mechanisms causing impaired adipokine production associated with
hypoxia are still elusive. We postulate that both cAMP response
element (CRE) binding protein activity in (CREB) and histone deace-
tylases are involved in these mechanisms. In support of this working
hypothesis, hypoxia can stimulate CREB activity as observed in PC12
and lung cells [15,16]. Adipocyte CREB activity is increased in obesity,
leading to increased abundance of the activating transcription factor 3
(ATF3) [17,18]. This increased ATF3 activity hampers the expression of
Adipoq and glucose transporter GLUT4, ultimately leading to impair-
ment in insulin-induced glucose uptake [17,18]. The CREB-dependent
activation mechanism is initiated by reduction in the content of
inducible cAMP early repressor (ICER), a natural antagonist of CREB
and other cAMP-dependent transcription factors [17]. Reduction of
ICER was found in adipocytes of human obese individuals and mice fed
a high fat diet (HFD) for 16 weeks [17]. In this study, therefore, we
hypothesized that defective deacetylase activity may account for the
collapse in the ICER level in obesity. Indeed, the expression of ICER is
reported to be positively regulated by histone deacetylase activity
(HDACs) in PC12 cells [19]. Overall, HDACs are pivotal in epigenetic
mechanisms that permit gene expression adaptation to environmental
changes [20]. There are 3 classes of HDACs [21,22]: classes I, II and
IV. Class I HDACs comprises HDAC1, HDAC2, HDAC3, and HDAC8.
Class II HDACs is divided into subclass IIa (HDAC4, HDAC5, HDAC7,
and HDAC9) and subclass IIb (HDAC6 and HDAC10). Class IV contains
includes HDAC11 only. So far, selective inhibition of HDACs is a
strategy for treating many cancers [22]. Additionally, there is emerging
evidence implicating Hdac activity in the control of energy metabolism,
thus opening an avenue for future targets in metabolic diseases [23]. In
the hypothalamus of obese mice fed a HFD, the expression of Hdacs,
including Hdac5, is modiﬁed when compared to that of mice fed a
chow diet [24,25]. Hdac5 is required for hypothalamic leptin signaling
and food intake, as Hdac5 knockout mice display defective hypotha-
lamic leptin signaling and are more prone to diet-induced obesity
compared to wild-type mice [25]. Given the role of HDACs in obesity,
we hypothesized the contribution of HDACs to the changes in adipokine
expression elicited by hypoxia and obesity-associated adipocyte
dysfunction.
2. MATERIAL AND METHODS
2.1. Materials
Trichostatin (TSA), tubastatin and LMK293 were obtained from Sigma-
Aldrich (St. Louis, MO).
2.2. Biopsies and RNA preparation
Total RNA was extracted from epididymal white adipose tissue (WAT)
of mice fed a HFD (n¼ 10) or normal chow diet (n¼ 10). WAT isolation
was performed in euthanized animals in accordance to the Swiss
legislation for animal experimentation. Approximately 5 cm3 of VAT
was obtained at the level of the omentum from ﬁve obese CaucasianFigure 2: Effects of hypoxia on Hdac activity and gene expression. Measurement of A
adipocyte cells. 3T3-L1 adipocyte cells were exposed for 12 h to normoxia or hypoxia (1%
hypoxia were further incubated with DMSO (Ctl) or a mixture of cAMP-raising agents IBMX
3T3-L1 adipocyte cells that were exposed for 12 h to normoxia or hypoxia (1% O2) and F
open bars) or siIcer (ﬁlled bars) for 72 h. The mRNA levels were normalized against the R
SEM of 3 independent experiments (***P < 0.001; **P < 0.01; *P < 0.05).
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surgery and ﬁve non-obese Caucasian women (24 < BMI <28 kg/m2)
[17]. All patients provided informed consent, and the study was
approved by the institutional review board [17]. The criteria for
exclusion and phenotyping are those previously described [17]. Total
RNA was isolated from adipose tissues and different cell fractions with
the TriPure isolation reagent (Roche) as previously described [17].
Procedure for preparation of adipocytes and SVF fractions was done as
described [17].
2.3. Cell culture and transfection
Culture and differentiation of 3T3-L1 cells were conducted as
described [17]. Brieﬂy, 3T3-L1 cells were grown and maintained in
Dulbecco’s modiﬁed Eagle’s medium high glucose containing 50 units/
ml penicillin, 50 mg/ml streptomycin, and 10% fetal calf serum (FCS) in
a 10% CO2 environment. At postconﬂuency (2 days), the cells were
differentiated by adding to the culture medium, isobutylmethylxanthine
(500 mM), dexamethasone (25 mM), and insulin (4 mg/ml) for 3 days
and then only with insulin for 3 more days. The medium was then
changed every 3 days until the cells were fully differentiated, typically
by 10 days. The 19-nt small interfering RNA (siRNA) duplex against Icer
(siIcer) is described elsewhere [17]. The siRNA duplexes, targeting the
GFP (50-CGCTGACCCTGAAGTTCAT-30), the mouse Hdac5 (50-GCAAG-
CATTCTACAACGAT-30), and Hdac6 (50-CCAGGACGATCTCCAAGAT-30)
were purchased from Microsynth (Balgach, Switzerland). For silencing
Icer, Hdac5, and Hdac6, on day 7 post-differentiation, 3T3-L1 adipo-
cytes were electroporated with siRNAs using the GenePulser XCell
(Bio-Rad) as previously described [17].
2.4. Western blotting and quantitative PCR
Protein extracts, western blotting, and real-time quantitative PCR were
conducted as previously described [17]. PCR assays were carried out
on a BioRad MyiQ Single-Color Real-Time PCR Detection System using
the BioRad iQ SYBR Green Supermix, with 100 nM primers and 1 ml of
template per 20 ml of PCR and an annealing temperature of 60 C. The
primer sequences are available in the supplementary materials.
2.5. 2-Deoxyglucose (2-DOG) uptake assay
2-deoxy-d-[1,2-3H]glucose (2-[3H]DOG, 26.2 Ci/mmol) uptake assays
were conducted on fully differentiated 3T3-L1 adipocytes (days 7 and
8) as previously described [17]. Adipocytes were treated without
(basal) or with insulin 10 nM for 10 min. 2-[3H]DOG (0.1 mCi; ﬁnal
concentration, 0.01 mmol/l) and 5 mM cold 2-DOG were then added
for an additional 10 min at 37 C. 2-DOG uptake was terminated by
washing the cells three times with ice-cold PBS containing 10 mM
glucose. Subsequently, cells were lysed in 1% (wt/vol) SDS and 0.2 M
NaOH. Incorporated radioactivity was measured by liquid scintillation
spectrometry.
2.6. Statistical analysis
The experiments including two groups were analyzed by t-test or with
the non-parametric equivalent Wilcoxon.) Hdac5 and Hdac6, B) Hdac activity, C) Icer and D) Atf3 mRNA levels in hypoxic 3T3-L1
O2). For inducing the expression of Icer and Atf3 in C) and D), cells under normoxia or
(100 mM)/Forskolin (10 mM) for 4 h. Quantiﬁcation of adipokine mRNA by qRT-PCR in E)
) upon silencing of Icer. 3T3-L1 adipocytes cells were electroporated with siGFP (siCtl,
plp0 and were expressed as the fold changes over the controls. Data are the mean of
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1203
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3.1. HDAC5/Hdac5 and HDAC6/Hdac6 mRNA levels are reduced in
adipocytes from obese human subjects and from obese mice
The total Hdac activity was monitored in WAT of mice that were fed a
chow diet or a HFD for 16 weeks. We and others have shown previ-
ously that mice gain more weight, develop more adipose tissue, and
develop systemic insulin resistance when fed a HFD [17]. The total
Hdac activity was signiﬁcantly decreased in the WAT of HFD mice
(Figure 1A). Decreased Hdac activity was associated with a signiﬁcant
drop of classes IIa and IIb, Hdac5 and Hdac6 expression, respectively
(Figure 1C,D). The level of all Hdac mRNA as well as the reduction of
Hdac5 and Hdac6 expression was conﬁrmed while the qRT-PCR an-
alyses were normalized against the TATA box binding protein mRNA,
for which we found that the level was also stable among the mice. In
contrast, Hdac9 expression was signiﬁcantly increased whereas the
expression of class I Hdacs (Hdac1-3 and Hdac8) was unchanged in
obese vs control mice (Figure 1B). The diminution of the two Hdacs had
originated in the mice adipocyte fraction (Figure 1E,F), whereas the
increased expression of Hdac9 was observed only in the adipose
stromal-vascular fraction (SVF) of obese mice (Figure 1G). Similar
results were found in human adipocytes and in SVF fractions of VAT
from obese individuals (Figure 1HeK). The collapse of total HDAC
activity (Figure 1H) was associated with a decrease in HDAC5 and
HDAC6 expression in human adipocyte fraction (Figure 1I,J). As
observed in mice, the HDAC9 expression was augmented in SVF
(Figure 1K). These results indicate a decrease in adipocyte expression
of HDAC5 and HDAC6 in human and mice obesity
3.2. Hypoxia mimics the reduction of Hdac5/HDAC5 and Hdac6/
HDAC6 mRNA and the loss of Icer activity in obesity
We hypothesized that the reduction of Hdac activity and mRNA level of
Hdac5 and Hdac6 in adipocytes is produced by hypoxia. Hypoxia re-
sults in increased lactate release, which is associated with an increase
of mRNAs of monocarboxylate transporters 1 and 4 (Mct1 and Mct4,
respectively) [26]. Here, we conﬁrmed that Mct1 and Mct4 levels were
increased in 3T3-L1 adipocytes cultured under hypoxia for 24 h
(Figure S1). Consistent with the induction of lactate metabolism by
hypoxia, the expression of both lactate dehydrogenase gene (Ldha) and
pyruvate dehydrogenase kinase 1 gene (Pdk1) were augmented
(Figure S1). These hypoxia-induced changes were associated with
decreased expression of both Hdac5 and Hdac6 (Figure 2A). Consis-
tently, the reduction of both Hdac5 and Hdac6 in response to hypoxia
was associated with a diminution of the total Hdac activity (Figure 2B).
The expression of hypoxia-sensitive genes has been shown to rely on
the increase of CREB activity [27,28]. Alteration of Icer level expression
may account for defective adipokine gene expression and increased
CREB activity caused by hypoxia. The expression of Icer, therefore, was
quantiﬁed in 3T3-L1 cells exposed to hypoxia. We found that hypoxia
alleviated the expression of Icer mRNA under non-stimulatory condi-
tions and in response to IBMX and Forskolin (Figure 2C). Parallel to the
diminution of Icer expression, as expected, the CREB target Atf3 level
was increased (Figure 2D), conﬁrming an increase of CREB tran-
scriptional activity by hypoxia. This result further suggested that
reduced Icer expression modiﬁes the expression of hypoxia-inducible
adipokines. Indeed, hypoxia affects the expression of numerous
genes encoding key adipokines involved in insulin resistance, including
Il6, Nampt, Agt, Lep, Adipoq, Lcn2, Retn, and Serpine1 [8,11,12,29e
32]. Culture of 3T3-L1 adipocytes under hypoxia signiﬁcantly
increased the level of Il6, Serpine1, and Lcn2, whereas it reduced the
mRNA of Retn, Agt, Lep, Nampt, and Adipoq (Figure 2E). The1204 MOLECULAR METABOLISM 5 (2016) 1200e1207  2016 The Author(s). Published by Elsevier GmbHexpression of these adipokines was monitored in 3T3-L1 adipocytes in
which the expression of Icer was silenced by small interfering RNAs
(siIcer). The efﬁciency and speciﬁcity of siIcer for reducing Icer
abundance in 3T3-L1 adipocytes has been reported in our previous
study [17]. Here, we showed that Icer silencing signiﬁcantly increased
the expression of Il6, Lcn2, and Serpine1, whereas that of Retn, Agt,
Lep, Nampt, and Adipoq was signiﬁcantly reduced (Figure 2F). In
humans, similar changes in adipokine levels were observed in the VAT
of obese subjects (Figure S2), in whom we previously found a
reduction in Icer activity [17]. Altogether, these data support a role for
adipocyte Hdac5 and Hdac6 in the control of Icer level and thereby in
hypoxia-sensitive adipokine expression in obesity.
3.3. Hdac5 and Hdac6 levels are required for the expression of Icer
and glucose uptake
We next investigated the role of Hdac5 and Hdac6 levels on Icer
expression. The efﬁcient silencing of both Hdac5 and Hdac6 in 3T3-L1
adipocytes using small interfering RNAs duplexes (siH5 and siH6) was
shown by Western Blotting analyses (Figure 3A). The reduction of
Hdac5 or Hdac6 level diminished the expression of Icer in 3T3-L1
adipocytes (Figure 3B). The induction of Icer by cAMP raising agents
IBMX and Forskolin was also attenuated upon silencing of both Hdacs
(Figure S3a). This result was conﬁrmed using Hdac inhibitors. The pan-
HDAC inhibitor trichostatin (TSA) attenuated basal Icer expression
(Figure S3b) and the induced expression of repressor in response to
cAMP raising agents IBMX and Forskolin in 3T3-L1 adipocytes
(Figure S3c). LMK 235 and tubastatin A are highly selective Hdac5 and
Hdac6 inhibitors, respectively [33,34]. Culture of 3T3-L1 adipocytes
with either LMK 235 or tubastatin A reproduced the effects of TSA on
the expression of Icer (Figure S3c). In agreement with the decrease of
Icer level by siH5 or siH6, we observed that the expression of Atf3 and
Glut4 was increased (Figure 3C,D). As anticipated, we found that the
reduction of Icer by siH5 or siH6 was accompanied by an impairment of
insulin-induced DOG uptake in 3T3-L1 adipocytes (Figure 3E), thus
supporting a role for HDAC5 and HDAC6 in the glucose transport in a
mechanism involving ICER (Figure 4).
4. DISCUSSION
Adipose reduction of Icer may be instrumental in the link between
obesity and systemic insulin resistance. In the present study, we
showed that the reduction of Icer in adipocytes of both obese mice and
obese human subjects is the consequence of impaired HDAC5/Hdac5
and HDAC6/Hdac6 expression. Indeed, among the 11 Hdacs expressed
in adipose tissue, only these two enzymes were down regulated, which
was sufﬁcient to lead to an overall reduction of Hdac activity and a
reduction of Icer expression. This result was further supported by the
silencing of Hdac5 or Hdac6 in 3T3-L1 adipocytes that also hampered
Icer expression. Post-translational modiﬁcations can modulate nuclear
activity and translocation of transcriptional regulators [35,36]. We
speculate that the defective activity of the two Hdacs in adipocytes
leads to re-acetylation and thereby inhibition of some transcription
factor(s) required for the Icer expression. In this case, increased Icer
expression may result from silencing the transcriptional repressor. This
mechanism has been suggested for the positive regulation of Icer by
HDAC activity in PC12 cells [19]. We speculate that HDAC5 and HDAC6
activate the expression of Icer in adipocytes via a similar mechanism.
Such regulation by the two HDACs may further rely on a concerted
mechanism. The two HDACs may be co-localized in the nucleus within
the gene coding for Icer. HDAC5 and HDAC6 can translocate from the
nucleus to the cytosol depending on the cell type and stress condition. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 3: Effect of silencing of Hdac5 and Hdac6 levels in 3T3-L1 adipocytes. A)
Efﬁciency of siRNAs on Hdac5 and Hdac6 content by Western Blotting. 3T3-L1 adi-
pocytes were electroporated with 5 nmol of control small interfering RNA duplexes
directed against GFP (siCtl) or with siRNAs against Hdac5 (siH5) or Hdac6 (siH6). Total
proteins were subjected to Western blotting experiments for the quantiﬁcation of
Hdac5, Hdac6, and a-tubulin as a loading control. The ﬁgure shows the results of a
representative experiment out of three. Effect of siH5 and siH6 on the B) expression of
Icer, C) Atf3, and D) Glut4 mRNA. Gene expression was monitored by quantitative real-
time PCR 72 h after transfection with either control small interfering RNA duplexes
directed against GFP (siCtl), or siH5, or siH6. mRNA levels were normalized against the
Rplp0 and were expressed as the fold changes over the controls. Data are the mean of
SEM of at least 3 independent experiments (***P < 0.001). E) Efﬁciency of siH5 and
siH6 on the 2-deoxy-glucose (DOG) uptake. Measurement of the labeled DOG in 3T3-L1
adipocytes cells was done 96 h after electroporation with siRNAs by measuring [1-3H]
2-DOG (100 mm, 0.5 mCi/ml) uptake from unstimulated cells (open bar) or stimulated
cell with 10 nM insulin (ﬁlled bar). Data are the mean of SEM of 4 independent
experiments (**P < 0.01; *P < 0.05).
ICER
Hypoxia
Obesity
Adipocyte
Glucose uptake
Adipoq, Agt, Lep, Nampt,
Retn, Glut4, Hsl
Serpine1, Il6, LCN2
Hdac5
Hdac6
Figure 4: Schematic representation for the role of Hdac5 and Hdac6 in coupling
hypoxia and obesity to defective Icer expression and adipocyte dysfunction.[37e39]. Moreover interaction of class IIa and class IIb HDACs is
possible. This was shown for HDCA6 and HDAC9 in GnRH neuronal
cells for modulating cell movement and survival [40]. Therefore, it is
possible that HDAC5 and HDAC6 act in concert for positively regulating
the expression of Icer via an indirect mechanism involving similar
nuclear or cytoplasmic targets in adipocyte. In contrast to adipocytes,
in SVF of obese subjects and mice, ICER/Icer expression is increased
[17]. We show in this study that increased ICER/Icer is associated with
the elevation of Hdac9/HDAC9 expression. Future studies are needed
to determine whether HDAC9 accounts for the increase of Icer and
thereby impacts cell function in SVF.
Icer is a passive transcriptional repressor that prevents binding of the
CREB transcriptional activator within CRE, leading to gene silencing.MOLECULAR METABOLISM 5 (2016) 1200e1207  2016 The Author(s). Published by Elsevier GmbH. This is an
www.molecularmetabolism.comThe antagonistic effect of ICER is a major mechanism that permits cells
to return to their basal state upon cAMP-raising conditions such as
fasting and glucagon and beta-adrenergic stimulation. In obesity, the
decrease of ICER/Icer in adipocytes increases the binding of CREB
within the CRE of its target genes [17,18], increasing the transcrip-
tional activity of CREB increases and the expression of its target ATF3
[17,18]. Herein, we showed not only ATF3 but also IL6, Serpine1, and
Lcn2 are increased, providing further evidence for a defective CREB
pathway in obesity. In contrast, the expression of Retn, Agt, Lep,
Nampt, and Adipoq were decreased upon Icer silencing. This suggests
that they are indirect targets of CREB.
The dysregulation of adipokines and altered Hdac5 and Hdac6 levels in
obesity are mimicked by hypoxia. We showed in 3T3-L1 adipocytes
that the changes in adipokine levels caused by hypoxia are associated
with impaired expression of the two Hdacs. We also found that adi-
pokine dysregulation caused by hypoxia is the consequence of
defective Icer activity. Silencing Icer in 3T3-L1 adipocytes mimicked
the effect of hypoxia on the expression of adipokines. Finally, we
propose that the reduction in Icer expression couples defective Hdac5
and Hdac6 activities to perturbed expression of adipokines and
adipocyte dysfunction caused by hypoxia and/or obesity (Figure 4).
Global methylation of histones and DNA is modiﬁed in adipose tissue
from obese subjects [41,42]. The main function of HDAC is to
deacetylate histones and non-histone proteins. Moreover, each HDAC
can have several targets. A reduction in Hdac5 and Hdac6 expression,
therefore, may lead to re-acetylation of several cytosolic and/or nuclear
proteins. In other words, the acetylome of adipocyte may be modiﬁed
in obesity. Some nuclear re-acetylated proteins may contribute directly
or indirectly to the deregulation of Icer and thereby to impaired adi-
pokine production, adipocyte dysfunction, and, ultimately, systemic
insulin resistance in the context of obesity.
Our study supports the requirement of maintaining Hdac5 and Hdac6
levels for optimal adipose function including glucose uptake and adi-
pokine genes expression. Appropriate expression of Hdac5 has been
shown to be required for energy metabolism in mice [25]. The
expression of Hdac5 is indeed decreased in the hypothalami of obese
mice [25]. Genetic and pharmacological inhibition of hypothalamic
Hdac5 impairs leptin signaling and has deleterious effects on food intake
and body-weight control [25]. Inhibition of some Hdacs, therefore, may
be detrimental for energy metabolism in human. While inhibition of the
class I HDAC Hdac3 has been seen as a promising therapeutic strategy
for diabetes [23,43e46], inhibition of Hdac8, in contrast, may cause
insulin resistance [47]. Moreover, there is a large spectra of class IIopen access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 1205
Brief CommunicationHDAC inhibitors that are currently used for the treatment of cancers [22].
For example, belinostat, abexinostat, and trichostatin target several
HDACs including HDAC5 and HDAC6 [22,34]. Therefore, it is possible
that inhibitors targeting Hdac5 and Hdac6 affect adipose function and
ultimately lead to insulin resistance. For optimal therapeutic metabolic
impact, our study suggests the need of reﬁning highly speciﬁc HDAC
inhibitors with low afﬁnity for HDAC5 and HDAC6.
5. CONCLUSION
We have identiﬁed altered adipocyte Hdac5 and Hdac6 expression in
obesity and associated hypoxia. Modeling the defect of the two Hdacs
in adipocytes by genetic silencing and selective inhibitors mimicked
the effect of hypoxia and obesity on the expression of key adipokines
and of Icer, the key regulator of adipokine transcription. We believe that
our ﬁndings provide a signiﬁcant hint for better understanding the
mechanism responsible of adipose dysfunction, obesity related insulin
resistance, and metabolic complications.
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